The Vectura board reportedly recommended the offer based purely on its value.Read More
Tags :Philip Morris International
The deal expands PMI's product development capabilities in inhaled therapeutics.Read More
The agreement will support biomedical research beyond PMI’s core businessRead More
The acquisition creates ‘beyond nicotine’ growth opportunities for the multinational.Read More
The rise is driven by a nearly doubling of counterfeit cigarettes in the EU. Read More
The Campaign for Tobacco-Free Kids says Philip Morris should not be welcomed anywhere. Read More
The tobacco giant’s operations center will remain in Lausanne, Switzerland.Read More
Fertin is the world’s biggest contract developer and manufacturer of the product.Read More
Martin King, CEO of PMI America, will retire at the end of August. Read More
The board also declared a regular quarterly dividend of $1.20 per common share.Read More